Financial reports
ARS
2023 FY
Annual report to shareholders
15 Mar 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
2 May 23
ARS
2022 FY
Annual report to shareholders
17 Mar 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
1 Aug 22
10-Q
2022 Q1
Quarterly report
2 May 22
10-K
2021 FY
Annual report
25 Feb 22
Current reports
8-K
Ameriprise Financial Reports Fourth Quarter 2023 Results
24 Jan 24
8-K
Other Events
9 Nov 23
8-K
Ameriprise Financial Reports Third Quarter 2023 Results
25 Oct 23
8-K
Ameriprise Financial Reports Second Quarter 2023 Results
26 Jul 23
8-K/A
Submission of Matters to a Vote of Security Holders
8 Jun 23
8-K
Departure of Directors or Certain Officers
28 Apr 23
8-K
Results of Operations and Financial Condition
24 Apr 23
8-K
Ameriprise Financial, Inc. Reports 2021 and 2022 Recast Results under LDTI
13 Apr 23
8-K
Other Events
9 Mar 23
8-K
Ameriprise Financial Reports Fourth Quarter 2022 Results
25 Jan 23
Registration and prospectus
S-3ASR
Automatic shelf registration
23 Feb 24
424B2
Prospectus for primary offering
8 Nov 23
FWP
Free writing prospectus
7 Nov 23
424B5
Prospectus supplement for primary offering
7 Nov 23
S-8 POS
Registration of securities for employees (post-effective amendment)
28 Apr 23
S-8
Registration of securities for employees
28 Apr 23
424B2
Prospectus for primary offering
7 Mar 23
FWP
Free writing prospectus
6 Mar 23
424B5
Prospectus supplement for primary offering
6 Mar 23
424B2
Prospectus for primary offering
11 May 22
Proxies
DEFA14A
Additional proxy soliciting materials
15 Mar 24
DEF 14A
Definitive proxy
15 Mar 24
PRE 14A
Preliminary proxy
1 Mar 24
DEFA14A
Additional proxy soliciting materials
23 Mar 23
DEFA14A
Additional proxy soliciting materials
17 Mar 23
DEF 14A
Definitive proxy
17 Mar 23
DEFA14A
Additional proxy soliciting materials
18 Mar 22
DEF 14A
Definitive proxy
18 Mar 22
DEFA14A
Additional proxy soliciting materials
19 Mar 21
DEF 14A
Definitive proxy
19 Mar 21
Other
UPLOAD
Letter from SEC
27 Jan 16
CORRESP
Correspondence with SEC
30 Dec 15
UPLOAD
Letter from SEC
16 Dec 15
UPLOAD
Letter from SEC
29 Jan 15
CORRESP
Correspondence with SEC
9 Jan 15
UPLOAD
Letter from SEC
10 Dec 14
UPLOAD
Letter from SEC
19 Dec 13
CORRESP
Correspondence with SEC
17 Dec 13
UPLOAD
Letter from SEC
5 Dec 13
CORRESP
Correspondence with SEC
10 Oct 13
Ownership
SC 13G/A
Outset Medical, Inc.
10 Apr 24
4
Gumer Alvero
29 Mar 24
4
Dawn M. Brockman
28 Mar 24
144
Notice of proposed sale of securities
27 Mar 24
144
Notice of proposed sale of securities
26 Mar 24
4
WILLIAM F TRUSCOTT
1 Mar 24
144
Notice of proposed sale of securities
28 Feb 24
4
Gerard P. Smyth
28 Feb 24
SC 13G/A
P3 Health Partners Inc.
27 Feb 24
4
Gumer Alvero
26 Feb 24